share_log
Reuters ·  Mar 25 06:30
Alumis and Kaken Pharmaceutical Announce Collaboration and Licensing Agreement for Esk-001 in Dermatology in Japan
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 213

Recommended

Write a comment